|Variable||No LGE||Midwall LGE||Infarct LGE||p Value|
|Subsequent AVR, %||55||46||53||0.66|
|Sudden cardiac deaths||0||3||0||—|
|All-cause mortality rate⁎||15.7||>142.7||>173.1||—|
|Cardiac mortality rate⁎||15.7||130.2||123.2||—|
|All-cause mortality rate⁎ in patients with AVR||13.7||53.8||73.6||—|
|All-cause mortality rate⁎ in non-AVR patients||18.2||218.8||190.0||—|
Values are the number of adverse events and the mortality rates (deaths per 1,000 patient/yrs) in each group.
AVR = aortic valve replacement; LGE = late gadolinium enhancement.
↵⁎ All-cause mortality rates are also displayed for patients who subsequently had an AVR during the period of follow-up and for those who did not (patients turned down for surgery have been excluded from this analysis [n = 2 in the midwall group, n = 4 in the infarct group]). p values for mortality rates are given in Table 3 and Figures 3 and 4.